lactic acid has been researched along with msh, 4-nle-7-phe-alpha- in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Bhardwaj, R; Blanchard, J; Brooks, C; Dorr, RT; Dvorakova, K; Hadley, ME | 1 |
Bassani, GA; Battistin, M; Brambilla, D; Carlin, A; Catania, A; Dondossola, DE; Gatti, S; Leonardi, P; Lonati, C; Merighi, R; Meroni, M; Zanella, A | 1 |
2 other study(ies) available for lactic acid and msh, 4-nle-7-phe-alpha-
Article | Year |
---|---|
Pharmacologic response of a controlled-release PLGA formulation for the alpha-melanocyte stimulating hormone analog, Melanotan-I.
Topics: alpha-MSH; Animals; Anticarcinogenic Agents; Chromatography, High Pressure Liquid; Delayed-Action Preparations; Drug Carriers; Drug Implants; Guinea Pigs; Lactic Acid; Melanins; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Pyrroles; Rana pipiens; Skin | 2000 |
NDP-MSH treatment recovers marginal lungs during ex vivo lung perfusion (EVLP).
Topics: Adenosine Triphosphate; alpha-MSH; Animals; Death; Hyaluronic Acid; Inflammation Mediators; Lactic Acid; Lung; Male; Organ Culture Techniques; Perfusion; Pulmonary Edema; Rats, Sprague-Dawley; Receptors, Melanocortin; Reperfusion Injury | 2021 |